Covestor’s SpringWorks Therapeutics SWTX Stock Holding History

Covestor’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-4	Closed	–	–	2754
2025 Q2	$0	Sell	4 -10,587	-100%	-$471K	﹤0.01%	2740
2025 Q1	$467K	Buy	10,591 +10,587	+264,675%	+$487K	0.31%	27
2024 Q4	$0	Hold	4	–	–	﹤0.01%	2722
2024 Q3	$0	Hold	4	–	–	﹤0.01%	2745
2024 Q2	$0	Hold	4	–	–	﹤0.01%	2736
2024 Q1	$0	Sell	4 -1	-20%	-$46	﹤0.01%	2719
2023 Q4	$0	Hold	5	–	–	﹤0.01%	2699
2023 Q3	$0	Sell	5 -1	-17%	-$27	﹤0.01%	2696
2023 Q2	$0	Hold	6	–	–	﹤0.01%	2633
2023 Q1	$0	Hold	6	–	–	﹤0.01%	2570
2022 Q4	$0	Buy	6 +2	+50%	+$49	﹤0.01%	2593
2022 Q3	$0	Sell	4 -1	-20%	-$29	﹤0.01%	2585
2022 Q2	$0	Sell	5 -1	-17%	-$37	﹤0.01%	2355
2022 Q1	$0	Sell	6 -2	-25%	-$114	﹤0.01%	2437
2021 Q4	$1K	Buy	+8	New	+$529	﹤0.01%	1945

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Covestor's SWTX Position: Q3 2025 in Review

Covestor sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 4 shares.

Covestor first reported a position in SWTX in Q4 2021 and held it in 15 quarters. The position peaked at $467K in Q1 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Covestor reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Covestor sold 4 SpringWorks Therapeutics shares in Q3 2025.
Covestor first reported a position in SpringWorks Therapeutics in Q4 2021 and held it in 15 quarters.
Covestor's SpringWorks Therapeutics position peaked at $467K in Q1 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Covestor's 13F filing for Q3 2025, filed 30 Oct 2025.